Velan (TSX:VLN) Stock Hit By Losses And Margin Compression

Velan stock closed at CA$17.49 after a choppy few weeks, with the share price down 6.5% over seven days and slightly weaker over one month. The headline today is not the top line; it is the hit to profitability. Q2 FY2027 brought in US$57.5m of revenue yet still produced a net loss of US$15.1m, heavily influenced by US$14.9m of one time transaction costs.

Short term traders are staring at red ink, while longer term investors are weighing that loss against a low roughly 1x price to sales ratio and a larger, still unprofitable, twelve month picture.

Like the low roughly 1x P/S on Velan but uneasy about ongoing losses and one time charges dragging earnings into the red? Consider screening for companies that combine modest valuations with cleaner income statements using our list of solid balance sheet and fundamentals stocks (7 results).

Q2 2027 Earnings Summary

• Revenue (Q2 2027 vs Q2 2026): US$57.54m vs. US$67.61m (fell 14.9%)
• Net Loss, Excluding Extra Items (Q2 2027 vs Q2 2026): US$15.05m loss vs. US$1.66m loss (loss widened significantly)
• Basic EPS (Q2 2027 vs Q2 2026): US$0.70 loss per share vs. US$0.08 loss per share (loss per share increased sharply)
• Trailing 12-Month Net Loss, Excluding Extra Items (TTM to Q2 2027 vs TTM to Q2 2026): US$25.34m loss vs. US$47.73m loss (TTM loss narrowed meaningfully)

If you prefer clear, visual charts instead of reading through a long earnings report and raw figures, view Velan's complete financial picture, including how its valuation compares at a glance, in the company report for Velan.

Velan bullish hopes hinge on backlog and liquidity

For investors leaning optimistic on Velan, two pillars still hold. The order book of US$262.5m, with 76% expected within 12 months, signals ongoing demand across nuclear, defense and power. Liquidity of about US$95.8m, including US$28.2m of cash and the new US$80m revolver, gives the business room to work through execution issues. Losses and soft quarterly bookings challenge any simple “steady industrial” story, but the combination of funded work and access to capital at least keeps a recovery narrative on the table.

Weak revenue, losses and restructuring fuel the bear view

The skeptical view on Velan finds support in recent results. Sales fell 14.9% year on year, adjusted EBITDA moved into a US$0.7m loss and adjusted net loss reached US$6.2m. Gross margin compressed to 21.9% and SG&A climbed to 29.4% of sales, so profitability deteriorated even before US$14.9m of transaction costs. Management has already cut headcount and suspended the dividend for fiscal 2027, which underlines pressure on the cost base and calls the earlier “steady, defensive industrial” narrative into question.

After restructuring charges, weaker margins and a history of earnings declines, are these setbacks isolated or structural? Review our independent risk analysis for Velan which shows 1 important warning sign

Stay Ahead With Velan And Beyond

Choppy results, restructuring costs and a low roughly 1x P/S ratio make Velan the kind of stock you might want to track closely rather than rush into. Register for free with Simply Wall St and add it to a Watchlist to watch how the share price moves against fair value estimates and wait for a setup that fits your approach. Once you own it, use the Portfolio Command Center to cut through noise and keep on top of only the most important developments across all your holdings. Round it out with the Community so you can see how other investors are thinking about the same risks and potential catalysts, helping you spot turning points early and stay ahead of the wider market.

Seeking Alternatives Beyond Velan Stock

Fresh ideas tend to move first. Late money often chases breakouts after momentum has already faded. Scan new lists that are under the radar for now, before the crowd, and focus on entering early.

• Identify restructuring candidates at an early stage and look for financially resilient turnaround stories using the curated list of solid balance sheet and fundamentals stocks (7 results) before they attract broader momentum trading.
• Monitor income opportunities and search for cash-generating businesses through our hand picked 3 dividend fortresses while yields remain compelling and prices have not yet accelerated.
• Look for growth at a considered entry point and review concentrated 9 high quality undiscovered gems lists while these businesses remain under the radar and before valuations react to increased attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com